Sareum
SAREUM HOLDINGS PLC Logo
About SAREUM HOLDINGS PLC
Sareum Holdings PLC is a clinical-stage biotechnology company focused on developing next-generation small molecule kinase inhibitors to treat autoimmune diseases and cancer. Its research pipeline primarily targets the TYK2/JAK1 kinase family, aiming to deliver innovative therapies with superior efficacy. Sareum advances molecules for autoimmune conditions, cancer, and viral infections, with a commitment to best-in-class potential in kinase inhibition.
Year founded
2004
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
